Trials / Completed
CompletedNCT05203991
Avascular Bone Necrosis in Sickle Cell Disease: a Pediatric Study.
Explorative Study on Occult Avascular Osteonecrosis in a Pediatric Patients Cohort With Sickle Cell Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 32 (actual)
- Sponsor
- San Luigi Gonzaga Hospital · Academic / Other
- Sex
- All
- Age
- 7 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
Avascular necrosis (AVN) is a serious complication of sickle cell disease, especially in pediatric patients where the prevalence is between 3% and 8% and are more frequent in patients with multiple vaso-occlusive crisis (VOC). The prevalence of AVN is usually made by a study of the hip through radiography, whereas other possible sites of ischemic infarcts are evaluated only in case of specific symptoms. In addition, bone infarcts may be the trigger for additional VOC. In this study, we want to investigate the presence of possible bone lesions even in asymptomatic or paucisymptomatic children. This is a prospective interventional and monocentric study whose objective is to describe the prevalence of osteonecrosis in children with sickle cell disease in Italy
Conditions
Timeline
- Start date
- 2021-03-18
- Primary completion
- 2021-10-27
- Completion
- 2021-10-27
- First posted
- 2022-01-24
- Last updated
- 2022-01-24
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05203991. Inclusion in this directory is not an endorsement.